Cargando…
168. Efficacy of the Novel gwt1 Inhibitor APX2039 in a Rabbit Model of cryptococcus Meningitis
BACKGROUND: Cryptococcal meningitis (CM), caused primarily by Cryptococcus neoformans, is uniformly fatal if not treated. Treatment options are limited especially in resource-poor geographical regions, and mortality rates remain high despite current therapies. New oral treatment options are needed t...
Autores principales: | Shaw, Karen J, Giamberardino, Charles D, Soltow, Quinlyn A, Tenor, Jennifer, Toffaletti, Dena, Boua, Jane-Valeriane, Marius, Choiselle, Palmucci, Julia R, Perfect, John R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777792/ http://dx.doi.org/10.1093/ofid/ofaa439.478 |
Ejemplares similares
-
Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis
por: Giamberardino, Charles D., et al.
Publicado: (2022) -
In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
por: Shaw, Karen Joy, et al.
Publicado: (2018) -
Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species
por: Kapoor, Mili, et al.
Publicado: (2019) -
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
por: Giamberardino, Charles D., et al.
Publicado: (2023) -
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental Coccidioides immitis Pneumonia
por: Viriyakosol, Suganya, et al.
Publicado: (2019)